PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 15 analysts with an average price target of $89.43. This is a potential upside of $19.07 (20.06%) from yesterday's end of day stock price of $74.49.

PTC Therapeutics's activity chart (see below) currently has 268 price targets and 233 ratings on display. The stock rating distribution of PTCT is 35.48% HOLD and 64.52% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.6% with an average time for these price targets to be met of 351.91 days.

Highest price target for PTCT is $130, Lowest price target is $55, average price target is $89.43.

Most recent stock forecast was given by BENJAMIN BURNETT from WELLS FARGO on 20-Jul-2026. First documented stock forecast 22-Jul-2014.

Currently out of the existing stock ratings of PTCT, 11 are a HOLD (35.48%), 20 are a BUY (64.52%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Feb-2026

$93

$16.18 (21.06%)

$95

10 days ago
(20-Jul-2026)

1/4 (25%)

$14.99 (19.22%)

137

Buy Since 21-Feb-2023

$130

$53.18 (69.23%)

$118

14 days ago
(16-Jul-2026)

15/21 (71.43%)

$51.48 (65.56%)

495

Hold Since 19-Feb-2026

$85

$8.18 (10.65%)

$82

23 days ago
(07-Jul-2026)

39/42 (92.86%)

$-4.2 (-4.71%)

124

Hold Since 02-Jun-2025

$108

$23.57 (27.92%)

1 months 21 days ago
(09-Jun-2026)

3/7 (42.86%)

$34.32 (46.58%)

42

Hold Since 27-May-2026

$85

$0.57 (0.68%)

$77

2 months 3 days ago
(27-May-2026)

4/5 (80%)

$14.34 (20.29%)

466

Show more analysts

Please expand the browser size to see the chart

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 351.91 days on average for the stock forecasts to be realized with a an average price target met ratio 79.6

Which analyst has the current highest performing score on PTCT (PTC Therapeutics) with a proven track record?

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

has 0 price targets and 0 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with highest potential upside - $53.18

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Simos Simeonidis with lowest potential downside - -$58.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?